The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Recombinant Follicle Stimulating Hormone Market Research Report 2025
Synopsis
Recombinant FSH is produced through recombinant DNA technology. These products are pure and do not contain the "contaminants" seen in urine extraction FSH. It is given subcutaneously with much less discomfort. Both human and genetically derived products are difficult to obtain and manufacture and are therefore expensive.
The global Recombinant Follicle Stimulating Hormone market was valued at US$ 1045.6 million in 2023 and is anticipated to reach US$ 1523 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
North American market for Recombinant Follicle Stimulating Hormone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Follicle Stimulating Hormone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Follicle Stimulating Hormone include Merck Serono, MSD, Techwell, GenSci, Gedeon Richter and Teva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Follicle Stimulating Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Follicle Stimulating Hormone.
Report Scope
The Recombinant Follicle Stimulating Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Follicle Stimulating Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Follicle Stimulating Hormone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Serono
MSD
Techwell
GenSci
Gedeon Richter
Teva
Segment by Type
75IU
150IU
Others
Segment by Application
Infertility Treatment
Assisted Reproductive Technology
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Follicle Stimulating Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Follicle Stimulating Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Recombinant FSH is produced through recombinant DNA technology. These products are pure and do not contain the "contaminants" seen in urine extraction FSH. It is given subcutaneously with much less discomfort. Both human and genetically derived products are difficult to obtain and manufacture and are therefore expensive.
The global Recombinant Follicle Stimulating Hormone market was valued at US$ 1045.6 million in 2023 and is anticipated to reach US$ 1523 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
North American market for Recombinant Follicle Stimulating Hormone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Follicle Stimulating Hormone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Follicle Stimulating Hormone include Merck Serono, MSD, Techwell, GenSci, Gedeon Richter and Teva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Follicle Stimulating Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Follicle Stimulating Hormone.
Report Scope
The Recombinant Follicle Stimulating Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Follicle Stimulating Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Follicle Stimulating Hormone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Serono
MSD
Techwell
GenSci
Gedeon Richter
Teva
Segment by Type
75IU
150IU
Others
Segment by Application
Infertility Treatment
Assisted Reproductive Technology
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Follicle Stimulating Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Follicle Stimulating Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Recombinant Follicle Stimulating Hormone Market Overview
1.1 Product Overview and Scope of Recombinant Follicle Stimulating Hormone
1.2 Recombinant Follicle Stimulating Hormone Segment by Type
1.2.1 Global Recombinant Follicle Stimulating Hormone Market Value Comparison by Type (2024-2030)
1.2.2 75IU
1.2.3 150IU
1.2.4 Others
1.3 Recombinant Follicle Stimulating Hormone Segment by Application
1.3.1 Global Recombinant Follicle Stimulating Hormone Market Value by Application: (2024-2030)
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Global Recombinant Follicle Stimulating Hormone Market Size Estimates and Forecasts
1.4.1 Global Recombinant Follicle Stimulating Hormone Revenue 2019-2030
1.4.2 Global Recombinant Follicle Stimulating Hormone Sales 2019-2030
1.4.3 Global Recombinant Follicle Stimulating Hormone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Follicle Stimulating Hormone Market Competition by Manufacturers
2.1 Global Recombinant Follicle Stimulating Hormone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Follicle Stimulating Hormone Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Follicle Stimulating Hormone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Follicle Stimulating Hormone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Follicle Stimulating Hormone, Product Type & Application
2.7 Recombinant Follicle Stimulating Hormone Market Competitive Situation and Trends
2.7.1 Recombinant Follicle Stimulating Hormone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Follicle Stimulating Hormone Players Market Share by Revenue
2.7.3 Global Recombinant Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Follicle Stimulating Hormone Retrospective Market Scenario by Region
3.1 Global Recombinant Follicle Stimulating Hormone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Follicle Stimulating Hormone Global Recombinant Follicle Stimulating Hormone Sales by Region: 2019-2030
3.2.1 Global Recombinant Follicle Stimulating Hormone Sales by Region: 2019-2024
3.2.2 Global Recombinant Follicle Stimulating Hormone Sales by Region: 2025-2030
3.3 Global Recombinant Follicle Stimulating Hormone Global Recombinant Follicle Stimulating Hormone Revenue by Region: 2019-2030
3.3.1 Global Recombinant Follicle Stimulating Hormone Revenue by Region: 2019-2024
3.3.2 Global Recombinant Follicle Stimulating Hormone Revenue by Region: 2025-2030
3.4 North America Recombinant Follicle Stimulating Hormone Market Facts & Figures by Country
3.4.1 North America Recombinant Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Follicle Stimulating Hormone Sales by Country (2019-2030)
3.4.3 North America Recombinant Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Follicle Stimulating Hormone Market Facts & Figures by Country
3.5.1 Europe Recombinant Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Follicle Stimulating Hormone Sales by Country (2019-2030)
3.5.3 Europe Recombinant Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Follicle Stimulating Hormone Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Follicle Stimulating Hormone Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Recombinant Follicle Stimulating Hormone Market Facts & Figures by Country
3.7.1 Latin America Recombinant Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Follicle Stimulating Hormone Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Follicle Stimulating Hormone Sales by Type (2019-2030)
4.1.1 Global Recombinant Follicle Stimulating Hormone Sales by Type (2019-2024)
4.1.2 Global Recombinant Follicle Stimulating Hormone Sales by Type (2025-2030)
4.1.3 Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Follicle Stimulating Hormone Revenue by Type (2019-2030)
4.2.1 Global Recombinant Follicle Stimulating Hormone Revenue by Type (2019-2024)
4.2.2 Global Recombinant Follicle Stimulating Hormone Revenue by Type (2025-2030)
4.2.3 Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Follicle Stimulating Hormone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Follicle Stimulating Hormone Sales by Application (2019-2030)
5.1.1 Global Recombinant Follicle Stimulating Hormone Sales by Application (2019-2024)
5.1.2 Global Recombinant Follicle Stimulating Hormone Sales by Application (2025-2030)
5.1.3 Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Follicle Stimulating Hormone Revenue by Application (2019-2030)
5.2.1 Global Recombinant Follicle Stimulating Hormone Revenue by Application (2019-2024)
5.2.2 Global Recombinant Follicle Stimulating Hormone Revenue by Application (2025-2030)
5.2.3 Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Follicle Stimulating Hormone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck Serono
6.1.1 Merck Serono Corporation Information
6.1.2 Merck Serono Description and Business Overview
6.1.3 Merck Serono Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Serono Recombinant Follicle Stimulating Hormone Product Portfolio
6.1.5 Merck Serono Recent Developments/Updates
6.2 MSD
6.2.1 MSD Corporation Information
6.2.2 MSD Description and Business Overview
6.2.3 MSD Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 MSD Recombinant Follicle Stimulating Hormone Product Portfolio
6.2.5 MSD Recent Developments/Updates
6.3 Techwell
6.3.1 Techwell Corporation Information
6.3.2 Techwell Description and Business Overview
6.3.3 Techwell Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Techwell Recombinant Follicle Stimulating Hormone Product Portfolio
6.3.5 Techwell Recent Developments/Updates
6.4 GenSci
6.4.1 GenSci Corporation Information
6.4.2 GenSci Description and Business Overview
6.4.3 GenSci Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GenSci Recombinant Follicle Stimulating Hormone Product Portfolio
6.4.5 GenSci Recent Developments/Updates
6.5 Gedeon Richter
6.5.1 Gedeon Richter Corporation Information
6.5.2 Gedeon Richter Description and Business Overview
6.5.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Gedeon Richter Recombinant Follicle Stimulating Hormone Product Portfolio
6.5.5 Gedeon Richter Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Recombinant Follicle Stimulating Hormone Product Portfolio
6.6.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Follicle Stimulating Hormone Industry Chain Analysis
7.2 Recombinant Follicle Stimulating Hormone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Follicle Stimulating Hormone Production Mode & Process
7.4 Recombinant Follicle Stimulating Hormone Sales and Marketing
7.4.1 Recombinant Follicle Stimulating Hormone Sales Channels
7.4.2 Recombinant Follicle Stimulating Hormone Distributors
7.5 Recombinant Follicle Stimulating Hormone Customers
8 Recombinant Follicle Stimulating Hormone Market Dynamics
8.1 Recombinant Follicle Stimulating Hormone Industry Trends
8.2 Recombinant Follicle Stimulating Hormone Market Drivers
8.3 Recombinant Follicle Stimulating Hormone Market Challenges
8.4 Recombinant Follicle Stimulating Hormone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Recombinant Follicle Stimulating Hormone Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Recombinant Follicle Stimulating Hormone Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Recombinant Follicle Stimulating Hormone Market Competitive Situation by Manufacturers in 2023
Table 4. Global Recombinant Follicle Stimulating Hormone Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Recombinant Follicle Stimulating Hormone Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Recombinant Follicle Stimulating Hormone Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Recombinant Follicle Stimulating Hormone Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Recombinant Follicle Stimulating Hormone, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Follicle Stimulating Hormone, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Follicle Stimulating Hormone, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Follicle Stimulating Hormone, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Follicle Stimulating Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Follicle Stimulating Hormone as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Follicle Stimulating Hormone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Recombinant Follicle Stimulating Hormone Sales by Region (2019-2024) & (K Doses)
Table 18. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Region (2019-2024)
Table 19. Global Recombinant Follicle Stimulating Hormone Sales by Region (2025-2030) & (K Doses)
Table 20. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Region (2025-2030)
Table 21. Global Recombinant Follicle Stimulating Hormone Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2019-2024)
Table 23. Global Recombinant Follicle Stimulating Hormone Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2025-2030)
Table 25. North America Recombinant Follicle Stimulating Hormone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Recombinant Follicle Stimulating Hormone Sales by Country (2019-2024) & (K Doses)
Table 27. North America Recombinant Follicle Stimulating Hormone Sales by Country (2025-2030) & (K Doses)
Table 28. North America Recombinant Follicle Stimulating Hormone Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Recombinant Follicle Stimulating Hormone Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Recombinant Follicle Stimulating Hormone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Recombinant Follicle Stimulating Hormone Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Recombinant Follicle Stimulating Hormone Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Recombinant Follicle Stimulating Hormone Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Recombinant Follicle Stimulating Hormone Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Recombinant Follicle Stimulating Hormone Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Recombinant Follicle Stimulating Hormone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Recombinant Follicle Stimulating Hormone Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Recombinant Follicle Stimulating Hormone Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Recombinant Follicle Stimulating Hormone Sales (K Doses) by Type (2019-2024)
Table 51. Global Recombinant Follicle Stimulating Hormone Sales (K Doses) by Type (2025-2030)
Table 52. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2019-2024)
Table 53. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2025-2030)
Table 54. Global Recombinant Follicle Stimulating Hormone Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Recombinant Follicle Stimulating Hormone Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2019-2024)
Table 57. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2025-2030)
Table 58. Global Recombinant Follicle Stimulating Hormone Price (USD/Dose) by Type (2019-2024)
Table 59. Global Recombinant Follicle Stimulating Hormone Price (USD/Dose) by Type (2025-2030)
Table 60. Global Recombinant Follicle Stimulating Hormone Sales (K Doses) by Application (2019-2024)
Table 61. Global Recombinant Follicle Stimulating Hormone Sales (K Doses) by Application (2025-2030)
Table 62. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2019-2024)
Table 63. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2025-2030)
Table 64. Global Recombinant Follicle Stimulating Hormone Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Recombinant Follicle Stimulating Hormone Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application (2019-2024)
Table 67. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application (2025-2030)
Table 68. Global Recombinant Follicle Stimulating Hormone Price (USD/Dose) by Application (2019-2024)
Table 69. Global Recombinant Follicle Stimulating Hormone Price (USD/Dose) by Application (2025-2030)
Table 70. Merck Serono Corporation Information
Table 71. Merck Serono Description and Business Overview
Table 72. Merck Serono Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. Merck Serono Recombinant Follicle Stimulating Hormone Product
Table 74. Merck Serono Recent Developments/Updates
Table 75. MSD Corporation Information
Table 76. MSD Description and Business Overview
Table 77. MSD Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. MSD Recombinant Follicle Stimulating Hormone Product
Table 79. MSD Recent Developments/Updates
Table 80. Techwell Corporation Information
Table 81. Techwell Description and Business Overview
Table 82. Techwell Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Techwell Recombinant Follicle Stimulating Hormone Product
Table 84. Techwell Recent Developments/Updates
Table 85. GenSci Corporation Information
Table 86. GenSci Description and Business Overview
Table 87. GenSci Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. GenSci Recombinant Follicle Stimulating Hormone Product
Table 89. GenSci Recent Developments/Updates
Table 90. Gedeon Richter Corporation Information
Table 91. Gedeon Richter Description and Business Overview
Table 92. Gedeon Richter Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Gedeon Richter Recombinant Follicle Stimulating Hormone Product
Table 94. Gedeon Richter Recent Developments/Updates
Table 95. Teva Corporation Information
Table 96. Teva Description and Business Overview
Table 97. Teva Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. Teva Recombinant Follicle Stimulating Hormone Product
Table 99. Teva Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Recombinant Follicle Stimulating Hormone Distributors List
Table 103. Recombinant Follicle Stimulating Hormone Customers List
Table 104. Recombinant Follicle Stimulating Hormone Market Trends
Table 105. Recombinant Follicle Stimulating Hormone Market Drivers
Table 106. Recombinant Follicle Stimulating Hormone Market Challenges
Table 107. Recombinant Follicle Stimulating Hormone Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Follicle Stimulating Hormone
Figure 2. Global Recombinant Follicle Stimulating Hormone Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Recombinant Follicle Stimulating Hormone Market Share by Type in 2023 & 2030
Figure 4. 75IU Product Picture
Figure 5. 150IU Product Picture
Figure 6. Others Product Picture
Figure 7. Global Recombinant Follicle Stimulating Hormone Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Recombinant Follicle Stimulating Hormone Market Share by Application in 2023 & 2030
Figure 9. Infertility Treatment
Figure 10. Assisted Reproductive Technology
Figure 11. Global Recombinant Follicle Stimulating Hormone Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Recombinant Follicle Stimulating Hormone Market Size (2019-2030) & (US$ Million)
Figure 13. Global Recombinant Follicle Stimulating Hormone Sales (2019-2030) & (K Doses)
Figure 14. Global Recombinant Follicle Stimulating Hormone Average Price (USD/Dose) & (2019-2030)
Figure 15. Recombinant Follicle Stimulating Hormone Report Years Considered
Figure 16. Recombinant Follicle Stimulating Hormone Sales Share by Manufacturers in 2023
Figure 17. Global Recombinant Follicle Stimulating Hormone Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Recombinant Follicle Stimulating Hormone Players: Market Share by Revenue in 2023
Figure 19. Recombinant Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Recombinant Follicle Stimulating Hormone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2019-2030)
Figure 22. North America Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2019-2030)
Figure 23. United States Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2019-2030)
Figure 26. Europe Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2019-2030)
Figure 27. Germany Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Recombinant Follicle Stimulating Hormone Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2019-2030)
Figure 34. China Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2019-2030)
Figure 44. Latin America Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Recombinant Follicle Stimulating Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Recombinant Follicle Stimulating Hormone by Type (2019-2030)
Figure 54. Global Revenue Market Share of Recombinant Follicle Stimulating Hormone by Type (2019-2030)
Figure 55. Global Recombinant Follicle Stimulating Hormone Price (USD/Dose) by Type (2019-2030)
Figure 56. Global Sales Market Share of Recombinant Follicle Stimulating Hormone by Application (2019-2030)
Figure 57. Global Revenue Market Share of Recombinant Follicle Stimulating Hormone by Application (2019-2030)
Figure 58. Global Recombinant Follicle Stimulating Hormone Price (USD/Dose) by Application (2019-2030)
Figure 59. Recombinant Follicle Stimulating Hormone Value Chain
Figure 60. Recombinant Follicle Stimulating Hormone Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
